Embolic Protection Devices Market Analysis

Embolic Protection Devices Market Analysis

To get key market trends

  Download Free Sample

The embolic protection devices market from distal filters segment is projected to reach USD 1.9 billion by 2032, depicting over 8.5% CAGR from 2023 to 2032. The availability of a wide range of specifications and the surging usage of distal filters are driving industry expansion. The fundamental advantage of using distal filters versus proximal occlusion devices is that they keep blood flowing while capturing big material. Furthermore, such filters retain an antegrade circulation of blood and are simple to use, thus, propelling market revenue.

The embolic protection devices market share from cardiovascular disease segment generated over USD 540 million in revenue in 2022 and is estimated to reach USD 1.3 billion by 2032. The global prevalence of cardiovascular disorders is attributable to segment expansion. According to CDC, heart disease is among the leading cause of death in the United States, with one person dying every 33 seconds from cardiovascular disease. The increasing demand for interventional methods to address these illnesses will increase the demand for effective cardiovascular devices to reduce the risk of consequences. The growing use of embolic protection devices in transcatheter aortic valve replacement, percutaneous coronary intervention, and other cardiac procedures will foster segment demand.

North America held over 35.5% share of the embolic protection devices market revenue in 2022 and is projected to be worth USD 1 billion by 2032. The rising prevalence of cardiovascular and neurovascular diseases in the region is driving market trends. Additionally, the strong foothold of major industry players, increasing incidence of obesity, lifestyle patterns, and unhealthy dietary habits will positively influence the regional market growth. According to a study published in the Harvard T.H. Chan School of Public Health, nearly two out of three or 69% adults in the U.S. are obese or overweight. Moreover, the ongoing R&D efforts, in line with the introduction of innovative and more effective embolic protection devices, will boost regional market gains.